Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Tarceva

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Tarceva was produced by Roche and Astellas.

AstraZeneca wins European approval for Tagrisso

AstraZeneca wins European approval for Tagrisso Almost two thirds of patients treated with older treatments such as AstraZeneca's Iressa (gefitinib), Boehringer Ingelheim's Giotrif (afatinib) or Roche/Astellas' Tarceva (erlotinib) develop the T790M mutation and face

Nine positive opinions for new drugs at CHMP meeting

Nine positive opinions for new drugs at CHMP meeting US. . The drug is a third-generation EGFR inhibitor, designed to overcome resistance to older drugs in the class such as Roche/Astellas' Tarceva (erlotinib), AZ's Iressa (gefitinib) and Boehringer

UK patients get early access to AZ's lung cancer drug Tagrisso

UK patients get early access to AZ's lung cancer drug Tagrisso The drug is a third-generation EGFR inhibitor, designed to overcome resistance to older drugs in the class such as Roche/Astellas' Tarceva (erlotinib), AZ's Iressa (gefitinib) and Boehringer

FDA clears Lilly's lung cancer drug Portrazza

FDA clears Lilly's lung cancer drug Portrazza Tarceva (erlotinib) and Boehringer Ingelheim's Giotrif (afatinib).

AZ sets price of new lung cancer drug Tagrisso

AZ sets price of new lung cancer drug Tagrisso The drug is a third-generation EGFR inhibitor, which is designed to overcome resistance to other drugs in the class such as Roche/Astellas' $2bn-a-year Tarceva (erlotinib), AZ's

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....
Cell and gene therapy
Tackling the manufacturing cost and complexity challenges...

Infographics